Pentoxifylline for steatohepatitis: Magic bullet or smoking gun?
- 28 October 2011
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 54 (5), 1496-1499
- https://doi.org/10.1002/hep.24612
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysisJournal of Hepatology, 2011
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trialHepatology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- A position statement on NAFLD/NASH based on the EASL 2009 special conferenceJournal of Hepatology, 2010
- Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseHepatology, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2010
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic SteatohepatitisGastroenterology, 2008
- The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver diseaseActa Diabetologica, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005